story of the week
Neoadjuvant Nivolumab and Relatlimab for Locally Advanced MMR-Deficient Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
Nat. Med. 2024 Sep 15;[EPub Ahead of Print], PGM de Gooyer, YL Verschoor, LDW van den Dungen, S Balduzzi, HA Marsman, MH Geukes Foppen, C Grootscholten, S Dokter, AG den Hartog, WHM Verbeek, K Woensdregt, JJ van den Broek, SJ Oosterling, TN Schumacher, KFD Kuhlmann, RGH Beets-Tan, JBAG Haanen, ME van Leerdam, JG van den Berg, M ChalabiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.